DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
E•••••••• I••
Healthcare & Pharmaceuticalsgroup grade Aoff every schedule since Sep 30, 2024sponsor unattributed
Nothing material in the last 200 days. Last change: 30 Sep 2024, Non-accrual at 1 of 1 lender on the latest schedules.
Mark path, consensus per quarter end
40¢ · 51¢ · 51¢ · 21¢ · 40¢Q3 2023 to Q3 2024
Principal held
at least $20.7M
sum of BDC pieces, a lower bound
Fair value
$8.3M
40c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
2
0 equity pieces beside them
Next maturity
Feb 14, 2025
$20.7M inside 24 months
On the tape since
Dec 31, 2021
latest Sep 30, 2024
Events
12
dated, non-routine
Lender marks
each lender's own fair value over cost at Sep 30, 2024, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| C•••••• S•••••• L••••••• I••• | $20.7M | 40¢ | +19 pts |
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| C•••••• S•••••• L••••••• I••• | term loan first lien F•••• L••• D••• | $20.7M | $8.3M 40c | S+375 bp |
Capital structure as the BDCs see it
latest quarter end Sep 30, 2024
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| other lien unstated exited Dec 31, 2021 | at least $21.3M | 99c | S+375 bp | Feb 14, 2025 | 1 |
| first lien term loan first lien exited Sep 30, 2024 | at least $20.7M | 40c | S+375 bp | Feb 14, 2025 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Sep 30, 2024 | 1 | $20.7M | $8.3M | 40c | 0 |
| Jun 30, 2024 | 1 | $20.7M | $4.4M | 21c | 0 |
| Mar 31, 2024 | 1 | $20.8M | $10.7M | 51c | 0 |
| Dec 31, 2023 | 1 | $41.7M | $21.3M | 51c | 0 |
All 10 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Sep 30, 2023 | 1 | $20.9M | $8.4M | 40c | 0 |
| Jun 30, 2023 | 1 | $21.0M | $10.4M | 50c | 0 |
| Mar 31, 2023 | 1 | $21.0M | $15.2M | 73c | 0 |
| Dec 31, 2022 | 1 | $42.2M | $34.0M | 81c | 0 |
| Sep 30, 2022 | 1 | $21.1M | $18.9M | 90c | 0 |
| Dec 31, 2021 | 1 | $42.6M | $42.1M | 99c | 0 |
What changed
- Facility left every BDC scheduleSep 30, 2024
- Mark recoveredSep 30, 2024
- Placed on non-accrualSep 30, 2024
- Marked down across lendersJun 30, 2024
- Marked down (one lender)Jun 30, 2024
Full timeline · 18 eventsShow fewer
- Mark recoveredDec 31, 2023
- Marked down across lendersSep 30, 2023
- Marked down (one lender)Sep 30, 2023
- Marked down across lendersJun 30, 2023
- Marked down (one lender)Jun 30, 2023
- Marked down across lendersMar 31, 2023
- Marked down (one lender)Mar 31, 2023
- Marked down across lendersDec 31, 2022
- Marked down (one lender)Dec 31, 2022
- Marked down across lendersSep 30, 2022
- Marked down (one lender)Sep 30, 2022
- New borrower on a BDC scheduleDec 31, 2021
- Facility left every BDC scheduleDec 31, 2021
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- EXACTECHderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it